Clinical Trial Update: GW824575 First Time in Human [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of GW824575 for retinal diseases was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Diseases

Drugs mentioned

• GW824575

Snippet

Sponsor: GlaxoSmithKline | Conditions: Retinal Diseases | Phase 1 | Status: TERMINATED